Olema Pharmaceuticals financials at a glance

+ Portfolio

The revenue of Olema Pharmaceuticals is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -2.12 Dollars per share in 2023, which was 45.56 lower than 2021. And about -0.065 billion Dollars are reported as free cash flow in the financials of Olema Pharmaceuticals 2023. No dividends were paid to the shareholders of the Olema Pharmaceuticals stock NasdaqGS:OLMA in the financial year 2023.

$0.00M

Revenue

$-2.62

Earnings Per Share

0.00%

Gross Margin %

$-82.43M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-2.62

Gross Margin %

0.00

Free Cash Flow

-82.43

Financials

Year	Year	TTM	2022	2021	2020
Rev.	Revenue	N/A	$0.00M	$0.00M	$0.00M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-2.31	$-2.62	$-1.80	$-3.42
Div.	Dividends	N/A	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	0	0
Sha.	Shares	N/AM	40.63M	39.85M	39.43M
OCF	Operating Cash Flow	N/A	$-82.07M	$-50.69M	$-19.87M
FCF	Free Cash Flow	N/A	$-82.43M	$-52.27M	$-19.92M
FCFS	Free Cash Flow Per Share	$-2.05	$-2.06	$-1.32	$-2.84

Olema Pharmaceuticals financials at a glance

Financials

Discover